Vinorelbine in pregnancy [3]

European Journal of Cancer Part A

Volumn 33, Issue 1, 1997, Pages 168-169

  Cuvier, C ^a   Espie, M ^a   Extra, J M ^a   Marty, M ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN; FLUOROURACIL; NAVELBINE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE;

ADULT; ANEMIA; BREAST CANCER; CASE REPORT; FEMALE; HUMAN; LETTER; NEWBORN; PREGNANCY; PRIORITY JOURNAL; BREAST TUMOR; FETOMATERNAL TRANSFUSION; PREGNANCY COMPLICATION; PREGNANCY OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; VINBLASTINE;

EID: 0031028534     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00356-5     Document Type: Letter

References (4)

1. VJ Wiebe PEH Sipila Pharmacology of antineoplastic agents in pregnancy Crit Rev Oncol Hematol 16 1994 75 112
2. HRK Barber Fetal and neonatal effects of cytotoxic agents Obstet Gynecol 58 1981 415 475
3. G Schaison C Jacquillat G Aucler Les risques foeto-embryonnaires des chimiothérapies Butt Cancer 66 1979 165 170
4. Dieras V, Extra JM, Belissant E, et al. Efficacy and tolerance of vinorelbine and fluorouracil combination as first line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method. J Clin Oncol , in press.